(134 days)
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and does not mention any AI/ML-specific features or performance metrics.
No
The device is described as a diagnostic mobile X-ray system for performing radiographic x-ray examinations, indicating its purpose is for imaging and diagnosis, not treatment.
Yes
The "Intended Use / Indications for Use" states the device performs "radiographic x-ray examinations," and the "Device Description" explicitly states it is a "diagnostic mobile X-ray system." Additionally, it mentions "acquiring medical diagnostic images."
No
The device description explicitly states it consists of hardware components such as an X-ray generator, image receptor(s), imaging display, and a motorized cart, in addition to software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "perform radiographic x-ray examinations on all pediatric and adult patient treatment areas." This describes an imaging device used for diagnostic purposes on the patient, not for testing samples in vitro (outside the body).
- Device Description: The description details a mobile X-ray system that acquires medical diagnostic images using digital radiography technology and a flat-panel detector. This is consistent with an imaging device, not an IVD.
- Input Imaging Modality: The input is "radiographic x-ray," which is an imaging modality, not a method for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, assays, or any other components typically associated with in vitro diagnostics.
In summary, the device is clearly described as a medical imaging system for performing X-ray examinations on patients, which falls outside the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The device is designed to perform radiographic x-ray examinations on all pediatric and adult patient treatment areas.
Product codes
IZL
Device Description
The DRX-Rise Mobile X-ray System is a diagnostic mobile X-ray system utilizing digital radiography technology. The DRX-Rise consists of a self-contained X-ray generator, image receptor(s), imaging display and software for acquiring medical diagnostic images outside of a standard stationary X-ray room. These components are mounted on a motorized cart that is battery powered to enable the device to be driven from location to location by user interaction.
The DRX-Rise system incorporates a flat-panel detector that can be used wirelessly for exams such as in-bed chest projections. The device acquires images using Carestream's clinical acquisition software platform (ImageView) and digital flat panel detectors. ImageView is considered software that is of Moderate Level of Concern and not intended for manipulation of medical images. The DRX-Rise Mobile X-ray System is designed for digital radiography (DR) with Carestream detectors.
The system also offers:
- A high-power, 32 kW generator
- A maneuverable drive system
- X-ray tube positioning in five axes of motion
- · Storage for detectors and supplies
- A touchscreen user interface
Mentions image processing
Carestream ImageView System software with image processing capability (K191025)
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Radiographic x-ray
Anatomical Site
Not Found
Indicated Patient Age Range
The device is designed to perform radiographic x-ray examinations on all pediatric and adult patient treatment areas.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
No clinical data is necessary to evaluate the safety or performance for purposes of determining substantial equivalence of modifications to the DRX-Rise System. The non-clinical testing demonstrates that the modified device is substantially equivalent to that of the predicate device.
- Product verification and validation is sufficient to assess safety and performance of the modified device.
- Non-clinical testing (consensus standards testing and third-party product safety testing) of the modified device are sufficient to evaluate the safety and performance and demonstrate substantial equivalence.
- The DRX-Rise complies with the following FDA-recognized consensus standards:
- AAMI ES60601-1:2005 +C1:A2: 2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005 (Third Edition) + CORR. 1:2006 + CORR. 2:2007 + A1:2012) (FDA Consensus Standards number 19-4)
- IEC 60601-1-6: 2010 + A1: 2013, Edition 3.1 - Medical electrical equipment – Part 1-6: General requirements for basic safety and essential performance – Collateral standard: Usability (FDA Consensus Standards number 5-89)
- IEC 60601-1-3:2008 (Second Edition) + A1:2013 Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment (FDA Consensus Standards number 12-269)
- IEC 60601-1-2:2014 Medical electrical equipment -- Part 1-2: General requirements for basic safety and essential performance -- Collateral Standard: Electromagnetic disturbances --Requirements and tests (FDA Consensus Standards number 19-8)
- IEC 60601-2-54:2009, AMD1:2015 Medical electrical equipment - Part 2-54: Particular requirements for the basic safety and essential performance of X-ray equipment for radiography and radioscopy (FDA Consensus Standards number 12-317)
- IEC 62366: 2007 + A1: 2014, Edition 1.0 - Medical devices - Application of usability engineering to medical devices (FDA Consensus Standards number 5-114)
- IEC 62304:2006 (First Edition) + A1:2015 Medical device software life-cycle processes (FDA Consensus Standards number 13-79)
- ISO 14971:2019 Medical devices - Applications of risk management to medical devices (FDA Consensus Standards number 5-125)
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
K150766, K153142, K183245, K163203, K193574, K160723, K180809
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1720 Mobile x-ray system.
(a)
Identification. A mobile x-ray system is a transportable device system intended to be used to generate and control x-ray for diagnostic procedures. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
March 23, 2022
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Carestream Health % Ms. Gina Maiolo Regulatory Affairs Manager 150 Verona Street ROCHESTER NY 14608
Re: K213568
Trade/Device Name: DRX-Rise Mobile X-ray System Regulation Number: 21 CFR 892.1720 Regulation Name: Mobile x-ray system Regulatory Class: Class II Product Code: IZL Dated: January 31, 2022 Received: February 7, 2022
Dear Ms. Maiolo:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Laurel Burk, Ph.D. Assistant Director Diagnostic X-ray Systems Team Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K213568
Device Name DRX-Rise Mobile X-ray System
Indications for Use (Describe)
The device is designed to perform radiographic x-ray examinations on all pediatric and adult patient treatment areas.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Carestream
510(k) Summary
DRX-Rise Mobile X-ray System (K213568)
Date Prepared: January 31, 2022
1. General Information
Carestream Health, Inc 150 Verona Street Rochester, New York 14608 Contact:
2. Contact Person
Gina Maiolo Regulatory Affairs Manager 585.627.6543 (Work) 516.395.0597 (Mobile)
3. Device Name and Classification
Trade Name: DRX-Rise Mobile X-ray System Classification Name: Mobile X-ray System Classification Panel: Radiology Classification Regulation: 21 CFR 892.1720 Device Classification: Class II Primary Product Code: IZL
4. Legally Marketed Predicate Device
Trade Name: DRX-Revolution Mobile X-ray System Classification Name: Mobile X-ray System Classification Panel: Radiology Classification Regulation: 21 CFR 892.1720 Device Classification: Class II Primary Product Code: IZL K191025
4
Image /page/4/Picture/0 description: The image shows the word "Carestream" in orange font. The font is sans-serif and appears to be slightly blurred. The background is white.
5. Device Description
The DRX-Rise Mobile X-ray System is a diagnostic mobile X-ray system utilizing digital radiography technology. The DRX-Rise consists of a self-contained X-ray generator, image receptor(s), imaging display and software for acquiring medical diagnostic images outside of a standard stationary X-ray room. These components are mounted on a motorized cart that is battery powered to enable the device to be driven from location to location by user interaction.
The DRX-Rise system incorporates a flat-panel detector that can be used wirelessly for exams such as in-bed chest projections. The device acquires images using Carestream's clinical acquisition software platform (ImageView) and digital flat panel detectors. ImageView is considered software that is of Moderate Level of Concern and not intended for manipulation of medical images. The DRX-Rise Mobile X-ray System is designed for digital radiography (DR) with Carestream detectors.
The system also offers:
- A high-power, 32 kW generator
- A maneuverable drive system
- X-ray tube positioning in five axes of motion
- · Storage for detectors and supplies
- A touchscreen user interface
6. Indications for Use
"The device is designed to perform radiographic x-ray examinations on all pediatric and adult patients, in all patient treatment areas."
7. Substantial Equivalence
The DRX-Rise Mobile X-ray System is substantially equivalent to the predicate device currently cleared on the market (K191025).
- . Both the predicate and the modified device (DRX-Rise) have the same principles of operation and share the same fundamental technology such as, an X-ray generator, Xray tube, collimator, and graphical user interface (GUI) that displays image acquisition software to support image management.
- The indications for use are the same as the predicate ●
- The predicate device (DRX-Revolution Mobile X-ray System) uses a Canon tube (model XRR-3336X) while the modified device (DRX-Rise Mobile X-ray System) uses a Canon tube (model E7242-X/FX/GX). There are minimal differences between the models such as kV and focal spot size. The modified device is substantially equivalent to the predicate in terms of kV range. The tube model used in the modified device does not significantly
5
change the functionality of the DRX-Rise system, nor impact safety and performance of the device or impact image quality.
- . The modified device is designed with a fixed column versus the automatic collapsible column on the predicate device. The height of the modified column is 1930 mm whereas the height of the column on the predicate is 2193mm-1390 mm. The column rotation remains the same (+/- 270 degrees). This design change does not impact safety or performance.
- . The modified device uses the same digital flat panel detectors that are designed to work across all Carestream Digital Radiography Systems. The detectors have either obtained clearance by separate submissions or with the digital radiography systems they are used with. The DRX-Rise is designed to be used with the legally marketed Carestream detectors:
- . The image Acquisition Software on the modified device is the same as that of the legally marketed device (K191025). Carestream's ImageView Software has already obtained clearance on several Carestream digital radiography systems:
6
Image /page/6/Picture/0 description: The image shows the word "Carestream" in a sans-serif font. The word is written in orange color. The background is white.
Table 1. Comparison of Technological Characteristics
| | DRX-Revolution Mobile
X-ray System (predicate
device K191025) | DRX-Rise Mobile X-
ray System (modified
device K213568) | Impact |
|--------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The device is designed to
perform radiographic X-ray
examinations on all
pediatric and adult patients,
in all patient treatment
areas. | *Same | |
| Imaging Device
Compatibility | Digital Radiography (DR) | *Same | |
| Digital Radiography
Imaging Device
(Detector) | DRX Plus Detectors
(K150766) (K153142)
(K183245) | *Same | |
| X-ray Generator Rating | 32kW | *Same | |
| mAs Range (Generator) | 0.1-320 mAs | 0.1 mAs~630 mAs | The DRX Rise (modified device) provides more power in generator output.
No impact to safety/performance |
| X-ray Tube Voltage Range | 40-150kV(1kV steps) | 40-125kV (1kV steps) | 40-125kV is the most commonly used kV range in clinical imaging. No impact to safety/performance |
| X-ray Tube Model | Canon/XRR-3336X | Canon/E7242 (X / FX / GX) | Same supplier but different tube model is used with the modified device. No impact to safety/performance |
| X-ray Tube Focal Spot Size | 0.6mm and 1.2mm | 0.6 mm and 1.5 mm | Small focal spot size is same as predicate. Large focus spot size is 20% larger but within expected range for clinical imaging. No impact to safety/performance or to image quality |
| System Power for Charging | Single Phase AC: 50/60 Hz, 1440 VA Voltage:100-240V | *Same | |
| Application System Software (Operator Console X-ray Control) | Carestream ImageView System software with image processing capability (K191025) | *Same | |
| Collapsible Column | Yes | No | The column is fixed on the modified device. No impact to safety/performance |
| Column Height | 2193mm-1390mm | 1930mm (fixed column) | No impact to safety/performance |
| Column Rotation Range | +/- 270 degrees | *Same | |
| Travel Method | Electric motor (battery powered) | *Same | |
7
Carestream
150 Verona St Rochester, NY 14608
8
Image /page/8/Picture/0 description: The image shows the word "Carestream" in orange color. The font is sans-serif and the letters are closely spaced. The word appears to be a logo or brand name.
8. Summary of Non-clinical Data
No clinical data is necessary to evaluate the safety or performance for purposes of determining substantial equivalence of modifications to the DRX-Rise System. The non-clinical testing demonstrates that the modified device is substantially equivalent to that of the predicate device.
- . Product verification and validation is sufficient to assess safety and performance of the modified device.
- Non-clinical testing (consensus standards testing and third-party product safety testing) of the modified device are sufficient to evaluate the safety and performance and demonstrate substantial equivalence.
- . The DRX-Rise complies with the following FDA-recognized consensus standards:
- AAMI ES60601-1:2005 +C1:A2: 2012 Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005 (Third Edition) + CORR. 1:2006 + CORR. 2:2007 + A1:2012) (FDA Consensus Standards number 19-4)
- IEC 60601-1-6: 2010 + A1: 2013, Edition 3.1 - Medical electrical equipment – Part 1-6: General requirements for basic safety and essential performance – Collateral standard: Usability (FDA Consensus Standards number 5-89)
- . IEC 60601-1-3:2008 (Second Edition) + A1:2013 Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment (FDA Consensus Standards number 12-269)
- IEC 60601-1-2:2014 Medical electrical equipment -- Part 1-2: General requirements for basic safety and essential performance -- Collateral Standard: Electromagnetic disturbances --Requirements and tests (FDA Consensus Standards number 19-8)
- IEC 60601-2-54:2009, AMD1:2015 Medical electrical equipment - Part 2-54: Particular requirements for the basic safety and essential performance of X-ray equipment for radiography and radioscopy (FDA Consensus Standards number 12-317)
- IEC 62366: 2007 + A1: 2014, Edition 1.0 - Medical devices - Application of usability engineering to medical devices (FDA Consensus Standards number 5-114)
- IEC 62304:2006 (First Edition) + A1:2015 Medical device software life-cycle processes (FDA Consensus Standards number 13-79)
- . ISO 14971:2019 Medical devices - Applications of risk management to medical devices (FDA Consensus Standards number 5-125)
9
Image /page/9/Picture/0 description: The image shows the word "Carestream" in orange font. The font is sans-serif and appears to be bolded. The background is white.
9. Summary of Guidance
Carestream has reviewed the following FDA Guidance and will meet the guidance recommendations as they apply to the DRX-Rise Mobile X-ray System.
- Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff Document Issued: October 2, 2014
- . Pediatric Information for X-ray Imaging Device Premarket Notifications Guidance for Industry and Food and Drug Administration Staff Document issued on November 28, 2017
- . Guidance for the Submission of 510(k)s for Solid State X-ray Imaging Devices Guidance for Industry and Food and Drug Administration Staff Document issued on: September 1, 2016
- Guidance for Industry and FDA Staff Guidance for the Content of Premarket Submissions for Software contained in Medical Devices, Document issued on: May 11, 2005 Medical Devices, Document issued on: May 11, 2005
- . Guidance for Industry and FDA Radio Frequency Wireless Technology in Medical devices Guidance for Industry and Food and Drug Administration Staff Document issued: August 14, 2013 Document issued: August 14, 2013
10
Carestream
10. Conclusion
The modified device (DRX-Rise Mobile X-ray System) is determined to be substantially equivalent to that of the legally marketed predicate device cleared under K191025. The following are the basis for substantial equivalence:
- Same Indications for use as the predicate device.
- Same principles of operation and technological characteristics as the legally marketed predicate device.
- Same components, including same imaging chain process and software (Eclipse II K180809) as the predicate.
- . Same image acquisition software (Carestream ImageView Software) is the same as that of the predicate and has been previously cleared on several Carestream digital radiography devices.
- Same flat panel detectors will be supported by the modified device. .